We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Hospira Expands European Launch of Remicade Biosimilar Inflectra
Hospira Expands European Launch of Remicade Biosimilar Inflectra
Injectables giant Hospira is launching its Remicade biosimilar Inflectra in at least 10 new European markets, nearly doubling the product’s presence on the continent.